Slate Path Capital LP
Q1 2020 13F-HR Holdings
Net value change ($000)
-552,518
(-29.8%)
New positions
7
Sold out positions
7
Turnover %
29.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Mylan II B.V. | 160,804 | NEW |
| IRWD | 13,521 | NEW |
| Endo International plc | 10,864 | 661.6% |
| B | 3,767 | 2.1% |
| W | 3,741 | NEW |
| ATRA | 3,574 | NEW |
| CYCN | 3,170 | NEW |
| BLUE APRON HLDGS INC | 1,473 | 69.9% |
| LX | 778 | 24.9% |
| RIG | 545 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| SNAP | -122,901 | -51.9% |
| BHC | -101,154 | -60.6% |
| KEX | -77,331 | -57.9% |
| MEDICINES CO /DE | -69,484 | -100.0% |
| MOS | -61,620 | -46.5% |
| ZG | -56,932 | -42.4% |
| EQT | -54,173 | -100.0% |
| FCX | -40,750 | -44.5% |
| Sibanye Gold Ltd | -39,075 | -100.0% |
| NYT | -25,624 | -16.2% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
11,365
(0.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|